1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical continuation of previous Department of War (DOW)-funded research and development efforts relevant to the FY26 JWMRP that augment and accelerate high-priority medical requirements to meet the needs of Service Members and other Military Health System beneficiaries. The MMRDA supports a wide range of research projects spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, translational, and clinical research. Projects must be relevant to at least one of the FY26 JWMRP focus areas.Distinctive Features:To be eligible for JWMRP funding, applicants/offerors must have already received DOD/DOW core or DOD/DOW Congressional Special Interest funding.An MMRDA Clinical Research or Clinical Trial Option (MMRDA-CRCTO) is available to specifically support clinical research/observational studies, all phases of clinical trials/interventional studies, and/or correlative studies in support of the development of promising pharmaceutical or biologic candidates, medical devices and technologies. Applicants/offerors should select MMRDA-CRCTO when the application/proposal involves research that includes any human subjects, human biological samples (prospective or retrospective) or human data sets. Note: If selecting this option, applicants must submit additional relevant application/proposal materials.
Funding Opportunity Number: HT942526JWMRPMMRDA. Assistance Listing: 12.420. Funding Instrument: CA,G,O,PC. Category: ST. Award Amount: $8.8M total program funding.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility. Confirm the full requirements in the official notice before applying.
The current listing shows $8.8M total program funding. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for DoW Joint Warfighter Medical, Military Medical Research and Development Award are due November 16, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Yes — DoW Joint Warfighter Medical, Military Medical Research and Development Award is offered by Defense Health Agency Contracting Activity - DHACA and this listing comes from Grants.gov, an official U.S. federal source. Federal applications generally require registrations (for example SAM.gov or an agency submission portal), so allow extra lead time.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The Long Range BAA is ONR's omnibus front door and the single most useful entry point for researchers who want Navy funding but are not responding to a named topic. It solicits Long-Range Science and Technology projects aimed at enhancing Navy and Marine Corps operations across science and engineering disciplines, and it is jointly issued with ONR Global and the Marine Corps Warfighting Laboratory - which matters because ONRG opens the door to non-U.S. performers and MCWL brings a distinct expeditionary problem set. For AI proposers the alignment is strong: ONR's 2026 Science and Technology Strategy names AI and autonomy as the organisation's top research focus, spanning machine learning, adversarial AI, intelligent agents, autonomous systems, and modelling and simulation. The strategy is built around a FEED at Speed framework and ties every research programme to a transition path, so proposals that articulate how a capability reaches the fleet are advantaged over those that stop at publication. ONR has additionally launched a strategic initiative to use AI to conduct basic and applied research rather than only to research AI for naval use cases, which opens space for AI-for-science proposals inside a defence portfolio. Eligibility is deliberately wide - all responsible sources from academia, industry and the research community worldwide may submit, and both small and large businesses compete, with the applicable SBA size standard at 1,000 employees. ONR does not publish per-award amounts. Submissions go through the ONR Submission Portal; FedConnect is no longer accepted as of Amendment 0004. The response deadline has been extended to 30 September 2026; the primary contact is Matthew Murray.
DoW Joint Warfighter Medical, Military Medical Research and Development Award is sponsored by Dept. of the Army -- USAMRAA. Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical continuation of previous Department of War (DOW)-funded research and development efforts relev…
Summary: The fiscal year 2026 (FY26) Joint Warfighter Medical Research Program (JWMRP) Military Medical Research and Development Award (MMRDA) mechanism is intended to fund the logical continuation of previous Department of War (DOW)-funded research and development efforts relevant to the FY26 JWMRP that augment and accelerate high-priority medical requirements to meet the needs of Service Members and other Military Health System beneficiaries. The MMRDA supports a wide range of research projects spanning late-stage preclinical studies, late-state technology development efforts, technology demonstration, translational, and clinical research. Projects must be relevant to at least one of the FY26 JWMRP focus areas.Distinctive Features:To be eligible for JWMRP funding, applicants/offerors must have already received DOD/DOW core or DOD/DOW Congressional Special Interest funding.An MMRDA Clinical Research or Clinical Trial Option (MMRDA-CRCTO) is available to specifically support clinical research/observational studies, all phases of clinical trials/interventional studies, and/or correlative studies in support of the development of promising pharmaceutical or biologic candidates, medical devices and technologies. Applicants/offerors should select MMRDA-CRCTO when the application/proposal involves research that includes any human subjects, human biological samples (prospective or retrospective) or human data sets. Note: If selecting this option, applicants must submit additional relevant application/proposal materials. Funding Opportunity Number: HT942526JWMRPMMRDA. Assistance Listing: 12.420. Funding Instrument: CA,G,O,PC. Category: ST. Award Amount: $8.8M total program funding.
HRSA-27-006 and HRSA-27-007 post September 18, 2026 and both close October 19 — $711.4 million across 189 awards for service areas that already have a health center in them. The incumbent is defending. Everyone else is holding a free option.
Read articleCDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleUSDA has obligated roughly $1 billion in emergency funds against New World screwworm and awarded $105 million to 40 Grand Challenge projects from 226 proposals. On September 2, 2026, DARPA pre-released a $2.1 million SBIR topic for networked screwworm detection. Four funding streams, four eligibility regimes, four clockspeeds — and most applicants only know about one.
Read article